Since there is a suggestion that PGRN could be an inflammatory biomarker of poor prognosis in acute stroke [46], the modulation of its level could raise the hypothesis of an anti-inflammatory role of creatine in the acute phase of stroke. This evidence concerns the gene GRN and stroke disorder.